These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 169697)

  • 21. Effects of ethanol on pathways of platelet aggregation in vitro.
    Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
    Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death.
    Patscheke H; Stegmeier K; Müller-Beckmann B; Sponer G; Staiger C; Neugebauer G
    Biomed Biochim Acta; 1984; 43(8-9):S312-8. PubMed ID: 6097235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Thrombocyte interaction with a collagen substrate: the role of thrombocyte-synthesized prostaglandin endoperoxides and thromboxane A2].
    Mazurov AB; Leĭtin VL; Repin VS
    Biull Eksp Biol Med; 1984 Nov; 98(11):563-6. PubMed ID: 6439262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the lonophore A23187 on the blood platelets II. Influence on ultrastructure.
    Gerrard JM; White JG; Rao GH
    Am J Pathol; 1974 Nov; 77(2):151-66. PubMed ID: 4447125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased synthesis of prostaglandin-E-like material by platelets from patients with diabetes mellitus.
    Halushka PV; Lurie D; Colwell JA
    N Engl J Med; 1977 Dec; 297(24):1306-10. PubMed ID: 917087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of prostaglandin endoperoxides and thromboxanes in platelet aggregation.
    Samuelsson B; Hamberg M; Malmsten C; Svensson J
    Adv Prostaglandin Thromboxane Res; 1976; 2():737-46. PubMed ID: 983874
    [No Abstract]   [Full Text] [Related]  

  • 27. Vitamin E and platelet function.
    Stuart MJ; Oski FA
    Am J Pediatr Hematol Oncol; 1979; 1(1):77-82. PubMed ID: 396795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the formation and effects of thromboxane A2 in human platelets.
    Svensson J; Hamberg M; Samuelsson B
    Acta Physiol Scand; 1976 Nov; 98(3):285-94. PubMed ID: 998278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of prostaglandins E1 and E2 on thrombocyte form and aggregation].
    Antonikov IM; Alekseev OV; Chernukh AM
    Biull Eksp Biol Med; 1982 Apr; 93(4):11-3. PubMed ID: 6952942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulated platelet aggregation, thromboxane B2 formation and platelet sensitivity to prostacyclin - a critical evaluation.
    Siess W; Roth P; Weber PC
    Thromb Haemost; 1981 Jun; 45(3):204-7. PubMed ID: 7025338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Synthesis of thromboxane A2: limiting stages of primary thrombocyte aggregation in humans initiated by arachidonic acid and its metabolic products].
    Mevkh AT; Basevich VV; Varfolomeev SD
    Biokhimiia; 1984 Dec; 49(12):2035-40. PubMed ID: 6441604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ticlopidine on platelet prostaglandin metabolism. Possible consequences for prostacyclin production.
    Lagarde M; Ghazi I; Dechavanne M
    Prostaglandins Med; 1979 Jun; 2(6):433-9. PubMed ID: 399526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostaglandin receptors on human platelets. Structure-activity relationships of stimulatory prostaglandins.
    MacIntyre DE; Salzman EW; Gordon JL
    Biochem J; 1978 Sep; 174(3):921-9. PubMed ID: 215124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation.
    Moncada S; Gryglewski RJ; Bunting S; Vane JR
    Prostaglandins; 1976 Nov; 12(5):715-37. PubMed ID: 824686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostaglandin endoperoxides and thromboxane A2 can induce platelet aggregation in the absence of secretion.
    Charo IF; Feinman RD; Detwiler TC; Smith JB; Ingerman CM; Silver MJ
    Nature; 1977 Sep; 269(5623):66-9. PubMed ID: 895887
    [No Abstract]   [Full Text] [Related]  

  • 36. Rat platelets aggregate in the absence of endogenous precursors of prostaglandin endoperoxides.
    Bult H; Bonta IL
    Nature; 1976 Dec; 264(5585):449-51. PubMed ID: 1004576
    [No Abstract]   [Full Text] [Related]  

  • 37. Prostaglandin endoperoxides and thromboxanes: role in platelets and in vascular and respiratory smooth muscle.
    Samuelsson B
    Acta Biol Med Ger; 1976; 35(8-9):1055-63. PubMed ID: 1007751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostaglandin E2 potentiation of platelet aggregation induced by LASS endoperoxide: absent in storage pool disease, normal after aspirin ingestion.
    Weiss HJ; Willis AL; Kuhn D; Brand H
    Br J Haematol; 1976 Feb; 32(2):257-72. PubMed ID: 1247498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation.
    Hamberg M; Svensson J; Wakabayashi T; Samuelsson B
    Proc Natl Acad Sci U S A; 1974 Feb; 71(2):345-9. PubMed ID: 4521806
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 15-Hydroperoxyeicosatetraenoic acid inhibits human platelet aggregation.
    Vericel E; Lagarde M
    Lipids; 1980 Jun; 15(6):472-4. PubMed ID: 7401944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.